| Q40242628 | A procedure for the quantitation of relaxed closed circular DNA in the presence of superhelical DNA: An improved fluorometric assay for nicking-closing enzyme |
| Q37683943 | Adenovirus infection elevates levels of cellular topoisomerase I. |
| Q72861979 | Analysis of Covalent Complexes Formed between Calf Thymus DNA Topisomerase and Single-Stranded DNA |
| Q28910371 | Biochemical and biophysical analyses of recombinant forms of human topoisomerase I |
| Q35729242 | Biodistribution and pharmacokinetics of colon-specific HPMA copolymer--9-aminocamptothecin conjugate in mice |
| Q72411577 | Breakage of single-stranded DNA by eukaryotic type 1 topoisomerase occurs only at regions with the potential for base-pairing |
| Q35760571 | Breakage of single-stranded DNA by rat liver nicking-closing enzyme with the formation of a DNA-enzyme complex |
| Q51555003 | Camptothecin and thiocamptothecin: the role of sulfur in shifting the hydrolysis equilibrium towards the closed lactone form. |
| Q28203339 | Camptothecins: a review of their chemotherapeutic potential |
| Q28327002 | Characterization of DNA topoisomerase I from Candida albicans as a target for drug discovery |
| Q37729428 | Common Chemical Inductors of Replication Stress: Focus on Cell-Based Studies |
| Q35360169 | DNA breakage and closure by rat liver type 1 topoisomerase: separation of the half-reactions by using a single-stranded DNA substrate |
| Q40260992 | DNA gyrase on the bacterial chromosome: DNA cleavage induced by oxolinic acid |
| Q70217258 | DNA strand breakage by wheat germ type 1 topoisomerase |
| Q35719729 | Drosophihlatopoisomerase I: isolation, purificatioann and characterization |
| Q35739215 | Ethidium bromide-mediated renaturation of denatured closed circular DNAs. The nature of denaturation-resistant fractions of bacteriophage PM2 closed circular DNA |
| Q72923454 | Intra- and intermolecular strand transfer by HeLa DNA topoisomerase I |
| Q36765809 | Mapping in vivo topoisomerase I sites on simian virus 40 DNA: asymmetric distribution of sites on replicating molecules |
| Q40495071 | Mechanistic study ofE. coliDNA topoisomerase I: cleavage of oligonucleotides |
| Q72650043 | Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine |
| Q22003729 | Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3'-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage |
| Q37481337 | Novel camptothecin derivatives as topoisomerase I inhibitors |
| Q35273563 | Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNA |
| Q35994662 | O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus |
| Q35104714 | Pharmacokinetic modeling of absorption behavior of 9-aminocamptothecin (9-AC) released from colon-specific HPMA copolymer-9-AC conjugate in rats |
| Q40534050 | Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors |
| Q71321842 | Phase II study of topotecan in metastatic hormone-refractory prostate cancer |
| Q40789846 | Preferential binding of human topoisomerase I to superhelical DNA. |
| Q34419803 | Proteins attached to viral genomes are multifunctional |
| Q40126918 | Proteins that shape DNA |
| Q40464254 | Recognition sites of eukaryotic DNA topoisomerase I: DNA nucleotide sequencing analysis of topo I cleavage sites on SV40 DNA. |
| Q57024691 | Residues within the N-terminal Domain of Human Topoisomerase I Play a Direct Role in Relaxation* |
| Q33222893 | Resistance mechanism development to the topoisomerase-I inhibitor Hoechst 33342 by Leishmania donovani |
| Q40819671 | Reverse gyrase binding to DNA alters the double helix structure and produces single-strand cleavage in the absence of ATP. |
| Q39633195 | Structure-activity relationship study of 16 a-thiocamptothecins: an integrated in vitro and in silico approach |
| Q40573727 | The DNA binding, cleavage, and religation reactions of eukaryotic topoisomerases I and II. |
| Q35952975 | The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I. |
| Q72901424 | The effect of salt on the binding of the eucaryotic DNA nicking-closing enzyme to DNA and chromatin |
| Q42204087 | Topoisomerase I amino acid substitutions, Gly185Arg and Asp325Glu, confer camptothecin resistance in Leishmania donovani |
| Q35072982 | Topoisomerase I is preferentially associated with normal SV40 replicative intermediates, but is associated with both replicating and nonreplicating SV40 DNAs which are deficient in histones |
| Q36832169 | Topoisomerase I sites cluster asymmetrically at the ends of the simian virus 40 core origin of replication |
| Q36688715 | Topoisomerase I-mediated integration of hepadnavirus DNA in vitro |